Royalty Pharma: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to Royalty Pharma| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 21 | URIST, MARSHALLMANHATTANNY10007 | BIOTECHNOLOGYROYALTY PHARMA | ACTBLUEC00401224 | 2024-08-03 | $13,300 | Primary (P) | EARMARKED FOR JOHN AVLON VICTORY FUND (C00880708)Filing 1817884FEC filing ↗ |
| 22 | LEGORRETA, PABLOMANHATTANNY10075 | CEOROYALTY PHARMA | ACTBLUEC00401224 | 2024-11-04 | $41,300 | Primary (P) | EARMARKED FOR DSCC (C00042366)Filing 1857001FEC filing ↗ |
| 23 | LEGORRETA, PABLONEW YORKNY10075 | CEOROYALTY PHARMA | DSCCC00042366 | 2024-11-04 | $41,300 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1857612FEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.